drugset / Trial / NCT01681836

Oral Nitrite and Nitrate in Healthy Normal Volunteer Adults

NCT01681836

Phase 1 Completed 11 enrolled Gladwin, Mark, MD
RandomizedCrossoverOpen-labelOther

Summary

This proposal hypothesizes that oral supplementation with sodium nitrite or nitrate will result in in vivo conversion of nitrate to nitrite and nitrite to nitric oxide with limited toxicity in the doses proposed in healthy adult normal volunteers. We utilize a powerful in vivo technique (pharmacokinetic testing) and are the first to design inorganic nitrate and nitrite capsules for cardiovascular disease.

Timeline

Start
2012-10
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Nitrate Other / unclassified 1000 mg Oral
Subject Sodium Nitrite Small molecule 20 mg Oral

Indications

No indication recorded.